All Stories

  1. Impact of Drone Versus Car Transport on Anti‐Doping Sample Integrity Over Short Distances: A Proof‐Of‐Concept Study
  2. Management of chronic urticaria: Current status and future prospect
  3. Chronic granulomatous disease: A multicenter study from the MENA region
  4. Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations
  5. Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
  6. Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort
  7. Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution
  8. Global disparities in adrenaline access: A World Allergy Organization call for equity in anaphylaxis care
  9. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
  10. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
  11. Characterization of ambient air quality and its relationship with respiratory morbidity in typical cities of Northwest China (NWC)
  12. Case Report: Not all recurrent “idiopathic” anaphylaxis is idiopathic
  13. A World Allergy Organization (WAO) manifesto for the worldwide approval of biologic therapies for food allergy
  14. Unmet needs in hereditary angioedema: an international survey of physicians
  15. Defining Clinical Remission in Severe Asthma: Expert Opinion From the Gulf Region Using the Modified Delphi Method
  16. In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar
  17. Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
  18. Contact Urticaria and Related Conditions: Clinical Review
  19. WAO - ARIA consensus on chronic cough: Executive summary
  20. Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
  21. Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years
  22. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  23. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
  24. Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study
  25. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
  26. Etiology of bronchiectasis in Qatar: A retrospective study
  27. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
  28. The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up
  29. Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
  30. Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity– a multicentric retrospective cohort study from the Arabian Peninsula
  31. Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
  32. Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
  33. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system
  34. Uncovering a neurological protein signature for severe COVID-19
  35. A review of patch-test data over the period of eight years in the allergy and immunology department in Qatar
  36. Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
  37. Case report: Challenges in the diagnosis of Eosinophilic esophagitis
  38. Circulating microRNA signatures in patients with chronic Urticaria
  39. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
  40. The Second Qatar Allergy and Immunology Conference: An Editorial
  41. The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
  42. Predictors of Early Death Among Untransplanted Patients with Combined immunodeficiencies affecting cellular and humoral immunity
  43. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity
  44. Predictors of early death risk among untransplanted patients with combined immunodeficiencies affecting cellular and humoral immunity: A multicenter report
  45. Anaphylaxis after prick‐to‐prick skin test to seafood allergy: A rare adverse event
  46. BCG Vaccine–associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity
  47. Aerobiological monitoring in a desert type ecosystem: Two sampling stations of two cities (2017–2020) in Qatar
  48. Digital tools in allergy and respiratory care
  49. Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
  50. Contributions of nurse specialists in the allergy and immunology service and patient care
  51. Do we need aerobiological air monitoring in desert climates? The Qatar experience
  52. Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
  53. Severity and outcome of COVID-19 disease in patients with allergic rhinitis during the pandemic in Qatar – A preliminary report
  54. Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease
  55. Aspirin challenge and desensitization in patients with suspected AERD in Qatar
  56. Circulatory EVs as a predictor of chronic urticarial activity
  57. First allergy conference in Qatar: Let's explore allergy with a new lens
  58. Real-world experience of the clinical effectiveness of omalizumab use in Qatar – a study protocol
  59. SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
  60. Correlation between skin test results and historical manifestations in patients with suspected lidocaine hypersensitivity
  61. First volumetric records of airborne Cladosporium and Alternaria spores in the atmosphere of Al Khor (northern Qatar): a preliminary survey
  62. Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
  63. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study
  64. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  65. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  66. The correlation between middle schoolchildren allergic symptoms and airborne particle season
  67. Viral exanthem following influenza vaccine
  68. A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar
  69. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
  70. Auto-Immunoproteomics Analysis of COVID-19 ICU Patients Revealed Increased Levels of Autoantibodies Related to Male Reproductive System
  71. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
  72. Association of endometriosis with interstitial cystitis in chronic pelvic pain syndrome: Short narrative on prevalence, diagnostic limitations, and clinical implications
  73. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  74. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  75. Abstract 13039: Putative Protective Effects Of Caffeine And Its Metabolites On Coronary Heart Disease In The Middle East
  76. Abstract 13041: Differences In Systemic Fatty Acids Between Coronary Heart Disease Patients And Controls From The Middle East Favors Inflammation
  77. Primary immunodeficiency and the microbiome
  78. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection
  79. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
  80. METABOLOMICS REVEALS PERTURBATIONS IN ARGININE-NO METABOLISM, PURINE BIOSYNTHESIS AND CELLULAR ENERGY CHARGE IN PATIENTS WITH CORONARY HEART DISEASE
  81. REPRODUCTIBILITY OF A METABOLITE RISK SCORE TO PREDICT CORONARY HEART DISEASE IN A MIDDLE EASTERN POPULATION
  82. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
  83. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications
  84. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
  85. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
  86. A founder RAB27A variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families
  87. The association between airborne pollen monitoring and sensitization in the hot desert climate
  88. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  89. Immunogenetics of Celiac Disease: A Focus on Arab Countries
  90. The Association Between Airborne Pollen Monitoring and Sensitization in the Hot Desert Climate
  91. Etiology and outcome of hemoptysis in Qatar, a high-resource country with a large expatriate population: A retrospective study
  92. A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
  93. Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study
  94. Delayed clavulanic acid–induced anaphylaxis in a patient undergoing bariatric surgery
  95. Complex Regional Pain Syndrome Type I Following Tetanus Toxoid Injection
  96. Two cases of food-dependent exercise-induced anaphylaxis with different culprit foods
  97. Renal allograft tuberculosis with infected lymphocele transmitted from the donor
  98. Primary Cutaneous Vasculitis Masquerading as Drug Induced following Aspirin Desensitization
  99. Two Cases of Recurrent Episodes of Angio Edema Without Urticaria or Pruritus
  100. Prevalence of Pharmacogenetic Risk Alleles in a Consanguineous Middle Eastern Population.